Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3582]

ASH 2023: Bispecific antibody drives myeloma precursor condition to undetectable levels in phase II trial

ASH 2023: Bispecific antibody drives myeloma precursor condition to undetectable levels in phase II trial

Can we crack this cancer’s immune response?

Can we crack this cancer’s immune response?

Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests

Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests

Gene splicing reduces effectiveness of CD20-targeting monoclonal antibodies designed to treat variety of blood cancers and disorders

Gene splicing reduces effectiveness of CD20-targeting monoclonal antibodies designed to treat variety of blood...

Scientists identify T-cell differentiation nodes to improve cancer-killing

Scientists identify T-cell differentiation nodes to improve cancer-killing

Shape-shifting immune cells offer new insights into cancer immunotherapy

Shape-shifting immune cells offer new insights into cancer immunotherapy

Viral reprogramming of cells increases risk of cancer in HIV patients

Viral reprogramming of cells increases risk of cancer in HIV patients

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery

ESMO 2023: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

ESMO 2023: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

ESMO 2023: Advances in gynaecological cancer research could change the treatment landscape

ESMO 2023: Advances in gynaecological cancer research could change the treatment landscape

More from ecancer